Drug Attacks Advanced Thyroid Cancer
A recent study shows that the chemotherapy drug vandetanib (Caprelsa) may extend life for some thyroid cancer patients. The results of phase 2 trials showed that patients taking the drug lived for 11 months without the cancer progressing, compared with six months...